Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence

Infection and Immunity

Volumn 68, Issue 5, 2000, Pages 2728-2734

  Carrillo, M Belen ^a,c   Gao, Wenda ^a   Herrera, Macario ^a   Alroy, Joseph ^b   Moore, Jeffrey B ^c,e   Beverley, Stephen M ^d   Pereira, Miercio A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; LEISHMANIA MAJOR; LEISHMANIASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION; TRANSGENE; TRYPANOSOMA CRUZI;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEURAMINIDASE; TRYPANOSOMA CRUZI; VIRULENCE;

EID: 0034017438     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.5.2728-2734.2000     Document Type: Article

References (30)

1. Beverley, S. M. 1996. Hijacking the cell: parasites in the driver's seat. Cell 78:787-789.
2. Chakkalath, H. R., A. A. Siddiqui, A. H. Shankar, D. E. Dobson, S. M. Beverley, and R. G. Titus. 2000. Priming of a β-galactosidase (βGAL)-specific type 1 response in BALB/c mice infected with βGAL-transfected Leishmania major. Infect. Immun. 68:809-814.
3. Chuenkova, M., and M. E. A. Pereira. 1995. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease. J. Exp. Med. 181:1693-1703.
4. Chuenkova, M., M. Pereira, and G. Taylor. 1999. trans-Sialidase of Trypanosoma cruzi: location of galactose-binding site(s). Biochem. Biophys. Res. Commun. 262:549-556.
5. Chuenkova, M., and M. A. Pereira. 2000. A trypanosomal protein synergizes with the cytokines CNTF and LIF to prevent apoptosis in neuronal cells. Mol. Biol. Cell, in press.
6. Falkow, S. 1988. Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10:S274-S276.
7. Ha, D. S., J. K. Schwarz, S. J. Turco, and S. M. Beverley. 1996. Use of the green fluorescent protein as a marker in transfected Leishmania. Mol. Biochem. Parasitol. 77:57-64.
8. Hall, B. F., P. Webster, A. K. Ma, K. A. Joiner, and N. W. Andrews. 1992. Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. J. Exp. Med. 176:313-325.
9. Hamer, D. H., H. Ward, S. Tzipori, M. E. Pereira, J. P. Alroy, and G. T. Keusch. 1994. Attachment of Cryptosporidium parvurn sporozoites to MDCK cells in vitro. Infect. Immun. 62:2208-2213.
10. Kapler, G. M., C. C. Coburn, and S. M. Beverley. 1990. Stable transfection of the human parasite Leishmania delineates a 30-kb region sufficient for extrachromosomal replication and expression. Mol. Cell. Biol. 10:1084-1094.
11. Launois, P., F. Tacchini-Cottier, C. Parra-Lopez, and J. A. Louis. 1988. Cytokines in parasitic diseases: the example of cutaneous leishmaniasis. Int. Rev. Immunol. 17:157-180.
12. LeBowitz, J. H., C. M. Coburn, D. McMahon-Pratt, and S. M. Beverley. 1990. Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes. Proc. Natl. Acad. Sci. USA 87:9736-9740.
13. Locksley, R. M., S. Pingel, D. Lacy, A. E. Wakil, M. Bix, and D. J. Fowell. 1999. Susceptibility to infectious diseases: Leishmania as a paradigm. J. Infect. Dis. 179:S305-S308.
14. Ming, M., M. Chuenkova, E. Ortega-Barria, and M. E. A. Pereira. 1993. Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosomes. Mol. Biochem. Parasitol. 59:243-252.
15. Mitchell, G. F. 1983. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major. J. Immunogenet. 10:395-412.
16. Parodi, A. J., G. D. Pollevick, M. Mautner, A. Buschiazzo, D. O. Sanchez, and A. C. C. Frasch. 1992. Identification of the gene(s) coding for the trans-sialidase of Trypanosoma cruzi. EMBO J. 11:1705-1710.
17. Pereira, M. E. A. 1983. A developmentally regulated neuraminidase activity in Trypanasoma cruzi. Science 219:1444-1447.
18. Pereira, M. E. A., J. S. Mejia, E. Ortega-Barria, D. Matzilevich, and R. P. Prioli. 1991. The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low-density lipoprotein receptor, and type III modules of fibronectin. J. Exp. Med. 174:179-191.
19. Pereira, M. E. A., K. Zhang, Y. Gong, E. M. Herrera, and M. Ming. 1996. Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase. Infect. Immun. 64:3884-3892.
20. Prioli, R. P., J. S. Mejia, and M. E. A. Pereira. 1990. Monoclonal antibodies against Trypanosoma cruzi neuraminidase reveal enzyme polymorphism, recognize a subset of trypomastigotes, and enhance infection in vitro. J. Immunol. 144:4384-4391.
21. Prioli, R. P., E. Ortega-Barria, J. S. Mejia, and M. E. A. Pereira. 1992. Mapping of a B-cell epitope present in the neuraminidase of Trypanosoma cruzi. Mol. Biochem. Parasitol. 52:85-96.
22. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
23. Rosenberg, I., R. P. Prioli, E. Ortega-Barria, and M. E. A. Pereira. 1991. Stage-specific phospholipases C mediated release of Trypanosoma cruzi neuraminidase. Mol. Biochem. Parasitol. 46:303-306.
24. Saavedra, E., M. Herrera, W. Gao, H. Uemura, and M. A. Pereira. 1999. The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, up-regulates interleukin-6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. J. Exp. Med. 190:1825-1836.
25. Sacks, D., and P. V. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223:1417-1419.
26. Schenkman, S. L., P. de Carvalho, and V. Nussenzweig. 1992. Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzyme. J. Exp. Med. 175:567-575.
27. Schenkman, S., D. Eichinger, M. E. A. Pereira, and V. Nussenzweig. 1994. Structural and functional properties of trypanosoma trans-sialidase. Annu. Rev. Microbiol. 48:499-532.
28. Schenkman, R. P., F. Vandekerckhove, and S. Schenkman. 1993. Mammalian cell sialic acid enhances Trypanosoma cruzi invasion. Infect. Immun. 61:898-902.
29. Scudder, P., J. P. Doom, M. Chuenkova, I. D. Manger, and M. E. A. Pereira. 1993. Enzymatic characterization of the β-D-galactoside α2,3-trans-sialidase from Trypanosoma cruzi. J. Biol. Chem. 268:9886-9891.
30. Titus, R. G., F. J. Gueiros-Filho, L. A. R. de Freitas, and S. M. Beverley. 1995. Development of safe live Leishmania vaccine lines by gene replacement. Proc. Natl. Acad. Sci. USA 92:10267-10271.